BBramley
TL3 Regular · Strasbourg, FR
Long-standing member. Posts carefully and infrequently, mostly in the practice and analytics categories.
Joined 28 December 2024 · last posted just now
145Posts here
1Topics
2Solutions
564Likes received
561Likes given
22Badges
175Days visited
2.9kPosts read
Recent activity
Full stream-
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #48 · Clinical › Bloodwork · 28 Jul 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
HbA1c lag and what it can and cannot tell you at eight weeks — one year on Replied, post #23 · Clinical › Bloodwork · 27 Jul 2026 · 27 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #85 · Practice › Dosing & titration · 21 Jul 2026 · 29 likes post #84 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Common supplements people ask about, assessed one at a time Replied, post #73 · Practice › Interactions · 20 Jul 2026 · 28 likes This follows post #70 rather than contradicting it. Metformin: commonly co-administered and relevant to gastrointestinal tolerability. Gastrointestinal side effects can…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #52 · Clinical › Prescriber conversations · 19 Jul 2026 · 18 likes How to ask for what you need: rather than "should I take this", frame it as "I understand the evidence for this shows X benefit in people with my condition; would it be…
-
Journal club: what we got wrong in an earlier session Replied, post #97 · Evidence › Journal club · 18 Jul 2026 · 0 likes I read post #95 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #111 · Devices › Syringes & needles · 18 Jul 2026 · 13 likes Syringe barrel size: common sizes are 0.3 mL, 0.5 mL, and 1.0 mL. Smaller barrels are more legible for small doses. Larger barrels hold larger volumes. Choose based on…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #85 · Meta › Announcements · 18 Jul 2026 · 8 likes Implementation timeline: announcements include when a change takes effect. Marking the date helps you know whether the change is already in effect.
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #71 · Compounds › Retatrutide · 18 Jul 2026 · 3 likes Coming back to post #69, because the follow-up matters more than the original answer. Triple agonism: is the effect additive, synergistic, or neither? A phase 2…
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #29 · Practice › Interactions · 15 Jul 2026 · 29 likes On post #25 — agreed on the reasoning, with one qualification. SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to…
-
Pooling trials with different estimands Replied, post #99 · Evidence › Meta-analyses · 15 Jul 2026 · 5 likes Why forest plots are more informative than pooled numbers: they show the variation across studies, which tells you whether the effect is consistent or heterogeneous. A…
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #15 · Access › Insurance & coverage · 10 Jul 2026 · 3 likes I read post #13 twice before replying, because I had assumed the opposite. Tier placement and step therapy: some formularies place a medication on a higher tier or…